Effects of the maternal and fetal proteome on birth weight: a Mendelian randomization analysis.

Abstract

Fetal growth is an indicator of fetal survival, regulated by maternal and fetal factors, but little is known about the underlying molecular mechanisms. We used Mendelian randomization to explore the effects of maternal and fetal genetically-instrumented plasma proteins on birth weight using genome-wide association summary data (n=406,063 with maternal and/or fetal genotype), with independent replication (n=74,932 mothers and n=62,108 offspring), and colocalisation. Higher genetically-predicted maternal levels of PCSK1 increased birthweight (mean-difference: 9g (95% CI: 5g, 13g) per 1 standard deviation protein level). Higher maternal levels of LGALS4 decreased birthweight (-54g (-29g, -80g)), as did VCAM1, RAD51D and GP1BA. In the offspring, higher genetically-predicted fetal levels of LGALS4 (46g (23g, 70g)) increased birthweight, alongside FCGR2B. Higher offspring levels of PCSK1 decreased birth weight (-9g (-16g, 4g), alongside LEPR. Results support maternal and fetal protein effects on birth weight, implicating roles for glucose metabolism, energy homeostasis, endothelial function and adipocyte differentiation.

• Authors: Nancy McBride, Alba Fernández-Sanlés, Marwa Al Arab, Tom A Bond, Jie Zheng, Maria C Magnus, Elizabeth C Corfield, Gemma L Clayton, Liang-Dar Hwang, Robin N Beaumont, David M Evans, Rachel M Freathy, Tom R Gaunt, Deborah A Lawlor, Maria Carolina Borges
• Journal: medRxiv : the preprint server for health sciences (medRxiv) (Oct 21 2023) United States
• PMID: 37904919 (Publication Type: Preprint)